Nexxt Spine has announced the completion of enrolment and six-month clinical data collection comparing the Nexxt Matrixx 3D-printed titanium interbody family to polyetheretherketone (PEEK) devices.
Jim Freid, the company’s director of development and clinical studies, said: “Results from the six-month data that was shared with Nexxt Spine demonstrated a significant increase in the fusion rates for both one- and two-level procedures, as compared to PEEK, (82% versus 25%).
“In addition, the analysis of subsidence of the interbody devices had only 11.8% of levels for the Nexxt Matrixx device showing subsidence greater than 2mm, while the PEEK device exhibited 55% of levels, showing that the Nexxt Matrixx technology has intrinsic benefits to patients and their outcomes.”
Nexxt Spine president, Andy Elsbury, added: “Nexxt Spine is grateful to physician researchers at The Ohio State University Wexner Medical Center for their time and effort in completing the six-month review of the study results, and looks forward to the final one-year data review.
“Here at Nexxt Spine we are committed to bringing exceptionally innovative products to the market. The Nexxt Matrixx proprietary 3D-printed technology continues to demonstrate positive clinical outcomes and positively enhance the lives of more patients.”
